Medical Health & Life Science Research News

Life science instrumentation market expected to reach USD 75.24 billion by 2022 published by leading research firm

Life science instrumentation market expected to reach USD 75.24 billion by 2022 published by leading research firm

Life Science Instrumentation Market Report of 2017 till 2022 has a detailed analysis of the market sector and discusses the corporate profiles in brief. It also derives industry insights and forecast for the Life Science Instrumentation Market.

- Agency -.

Life Science Instrumentation Market Report is an analytical guide providing information about the key company profiles, industry insights and market forecast. The Life Science Instrumentation Market Report is brief research study about the corporate opportunities present in the future for the Life Science Instrumentation industry.

The global life science instrumentation market is expected to reach USD 75.24 billion by 2022 from USD 54.49 million in 2017, at a CAGR of 6.7%. Increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are some of the key factors driving the growth of this market.

- Agency -.

However, the high cost of instruments and the dearth of skilled professionals are expected to restrain market growth to a certain extent.

Complete report on Life Science Instrumentation Market spread across 159 pages, profiling 25 companies and supported with 356 tables and 50 figures is now available at www.reportsnreports.com/reports/14…a-sequencer.html

By technology, the life science instrumentation market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The spectroscopy segment is expected to account for the largest share of the global life science instrumentation market in 2017owing to the increasing use of spectroscopy instruments in the drug safety process.

In addition, the increasing use of spectroscopy in combination with other technologies, such as chromatography, in various applications is also driving the growth of this market.

On the basis of application, the life science instrumentation market is segmented into research applications, clinical and diagnostic applications, and other applications. The research applications segment is expected to account for the largest share of the global life science instrumentation market in 2017 owing to launch of technologically advanced life science instruments for the drug discovery process, increasing research activities, growth in the number of preclinical and clinical trials, and increasing adoption of high-throughput life science instruments in drug development and drug discovery.

While North America is expected to account for the largest share of the market in 2017, APAC is expected to register the highest growth rate during the forecast period (2017-2022). This is owing to the rising focus of key market players in emerging Asian countries; increasing crop research studies in Asia to feed its growing population; the growing pharmaceutical industry in India and China; the large biomedical industry in Singapore; and rising number of conferences, exhibitions, and meetings on analytical instruments across the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

By Company Type - Tier 1 –25%, Tier 2 –30% and Tier 3 –45%

By Designation – C level – 12%, Director level – 24%, Others – 64%

By Region – North America - 34%, Europe – 26%, APAC – 35%, RoW – 5%

The major players in the market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc.

(US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc.

(US), Waters Corporation (US), Shimadzu Corporation (Japan), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc.

(US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Hitachi High-Technologies Corporation (Japan), Eppendorf AG (Germany), QIAGEN N.V. (Netherlands), GE Healthcare (US), and Merck KGaA (Germany), among others.

Ask for Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022 at www.reportsnreports.com/contacts/d…aspx?name=148902

This report studies the life science instrumentation market based on technology, applications, and end users. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.

It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total market.

The report forecasts the revenue of the market segments with respect to four main regions.

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.